Gennex Laboratories Ltd. Share Price & Stock Analysis

Gennex Laboratories Ltd. (BSE: 531739) is a Hyderabad, Telangana-based company in the Pharmaceuticals industry. With a market capitalisation of ₹223 Cr, it ranks #2,556 by market cap among the 6,197 Indian listed companies on FinBizNet, and #36 of 63 in Pharmaceuticals. At ₹9.35 (as of 16 Nov 2026), the share price is 42.2% below its 52-week high of ₹16.18 and 32.6% above its 52-week low of ₹7.05. The share price is down 33.9% over one year and down 0.9% over three months.

Key Metrics

Current Price₹9.35
Market Cap₹223 Cr
BSE Code531739
SectorHealth Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals
Sub-IndustryBiotechnology and Life Sciences > Pharmaceuticals
P/E Ratio10.6
Return on Equity9.82%
Return on Assets4.11%
52-Week Range₹7.05 – ₹16.18
1-Year Price Change-33.9%
3-Month Price Change-0.9%
Beta (1Y)0.86
HeadquartersHyderabad, Telangana
Websitewww.gennexlab.com

Shareholding and Delivery

Delivery averaged 77.2% of traded volume across 15 BSE sessions (21 Oct 2026 – 13 Nov 2026).

About Gennex Laboratories Ltd.

Gennex Laboratories Limited manufactures and sells bulk drugs, intermediates, and biotech products. The company offers Guaifenesin, an expectorant used as a mucolyte; Methocarbamol for skeletal muscle relaxant; Fexofenadine Hcl for treating antihistamines; Phenazopyridine Hcl for the treatment of urinary tract analgesic; Fluconazole for antifungals; Melitracen Hcl for treating tricyclic antidepressant; Sertraline Hcl, a selective serotonin reuptake inhibitor; Chlorphenesin and Mephenesin for muscle relaxant; and Allopurinol, a xanthine oxidase inhibitor. It has operations in India, Algeria, Bangladesh, Barzil, Bolivia, Colombia, the Czech Republic, Egypt, El Salvador, Germany, Guatemala City, Mexico, Peru, Spain, Turkey, Thailand, the United Arab Emirates, and Vietnam. Gennex Laboratories Limited was formerly known as Prudential Pharmaceuticals Limited and changed its name to Gennex Laboratories Limited in September 2007. Gennex Laboratories Limited was incorporated in 1985 and is base

Products and Services

1. Bulk Drugs,Biotech Products and Intermediates-This segment manufactures bulk drugs, intermediates, and biotech products. 2. Other-0 3. Segment Adjustment-0

Business Segments

1. Bulk Drugs, Biotech Products and Intermediates-100%

Gennex Laboratories Ltd. vs Peers — Pharmaceuticals

CompanyMarket CapP/EROELatest Qtr Revenue1Y Change
Abbott India Ltd.₹56,531 Cr36.334.46%₹1,814 Cr-8.1%
Emcure Pharmaceuticals Ltd₹42,344 Cr47.919.57%₹2,820 Cr+73.3%
Ajanta Pharma Limited₹41,474 Cr39.425.39%₹1,794 Cr+27.8%
Piramal Pharma Ltd₹32,600 Crn/m-4.00%₹2,617 Cr+22.8%
RUBICON RESEARCH LIMITED₹28,526 Cr112.319.14%₹576 Cr+162.7%
Caplin Point Laboratories Ltdte₹18,155 Cr28.319.94%₹630 Cr+23.6%
Pfizer Ltd.₹17,811 Cr24.517.16%₹727 Cr-24.2%
Eris Lifesciences Ltd₹17,691 Cr28.318.07%₹892 Cr-17.5%
Gennex Laboratories Ltd.₹223 Cr10.69.82%—-33.9%

Listed by market capitalisation. Ratios are shown for context only.

Frequently Asked Questions

What is the current share price of Gennex Laboratories Ltd.?

Gennex Laboratories Ltd. is trading at ₹9.35, with a market capitalisation of ₹223 Cr.

Which sector does Gennex Laboratories Ltd. belong to?

Gennex Laboratories Ltd. operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Biotechnology and Life Sciences > Pharmaceuticals).

What are the key financial ratios of Gennex Laboratories Ltd.?

Gennex Laboratories Ltd. has a P/E of 10.6 and a return on equity of 9.82%.

What is the stock symbol of Gennex Laboratories Ltd.?

Gennex Laboratories Ltd. is listed on the BSE under the scrip code 531739.

How has Gennex Laboratories Ltd.'s share price moved over the past year?

Gennex Laboratories Ltd.'s share price is down 33.9% over one year and down 0.9% over three months. Its 52-week range is ₹7.05 to ₹16.18.

More on FinBizNet

Data as of 16 Nov 2026. Descriptive market data only — not investment advice.